Overview
Announcements

Ordinary Index Rebalancing in the Solactive Pharma & Biotech Opportunity Index | August 2020

In the ordinary rebalance the following composition will be implemented effective open 20.08.2020:

3SBIO INC
AGIOS PHARMACEUTICALS INC
ALKERMES PLC
AMARIN CORPORATION PLC -ADR
BLUEBIRD BIO INC
CHINA BIOLOGIC PRODUCTS HOLD
CHINA MEDICAL SYSTEM HOLDINGS LTD
CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO LTD
CSPC PHARMACEUTICAL GROUP LTD
EMERGENT BIOSOLUTIONS INC
EXELIXIS INC
GALAPAGOS NV
HANMI PHARM CO LTD
IONIS PHARMACEUTICALS INC
IPSEN SA
JAZZ PHARMACEUTICALS PLC
KALBE FARMA TBK PT
LUYE PHARMA GROUP LTD
MORPHOSYS AG
NEKTAR THERAPEUTICS
NIPPON SHINYAKU CO LTD
ONO PHARMACEUTICAL CO LTD ORD
PTC THERAPEUTICS INC
RICHTER GEDEON VEGYESZETI GYAR NYILVANOSAN MUKODO RT.
SANTEN PHARMACEUTICAL CO LTD ORD
SAWAI PHARMACEUTICAL CO LTD ORD
SIEGFRIED HOLDING AG-REG
SUMITOMO DAINIPPON PHARMA CO ORD
SWEDISH ORPHAN BIOVITRUM AB
VIFOR PHARMA AG